DRIO
$8.75
DarioHealth Corp.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by dat...
Recent News
OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates
OPKO Health (OPK) delivered earnings and revenue surprises of +39.39% and +7.56%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
How The DarioHealth (DRIO) Story Is Shifting With A Higher Target And Ongoing Risks
What Changed In The Latest DarioHealth Price Target The latest DarioHealth update keeps the fair value estimate steady at 18.25, while making only a slight tweak to the discount rate to about 9.18% and holding long term revenue growth assumptions at roughly 11.40%. These small shifts reflect analysts trying to balance a higher stated price target of US$11 with a cautious read on current revenue trends and the reliance on a future pipeline to support the story. As you read on, keep an eye on...
Why The Narrative Around DarioHealth Is Shifting After New Results And Valuation Updates
DarioHealth's latest price target update keeps fair value steady at $18.25, even as analysts fine tune their discount rate and revenue growth assumptions to reflect a mix of near term pressure and longer term potential. The slight rise in the discount rate and essentially unchanged revenue growth outlook highlight an ongoing debate about execution risk versus the strength of the company’s growth pipeline. Stay tuned to see how you can follow these evolving targets and the shifting narrative...
What Catalysts Are Changing the Narrative for DarioHealth?
DarioHealth recently saw its consensus analyst price target lowered from $19.75 to $18.25. This adjustment reflects a cautious reassessment of the company's growth trajectory. Market watchers are weighing both positives, such as a promising new product pipeline, alongside persistent concerns over recent revenue trends. Stay tuned to discover how investors can track these shifts and remain informed about the evolving DarioHealth story. Stay updated as the Fair Value for DarioHealth shifts by...
How the Narrative Around DarioHealth Is Shifting After Key Strategic and Analyst Updates
Analysts have recently lowered their consensus price target for DarioHealth from $22.25 to $19.75. This change reflects shifting expectations for the company's short-term performance as the discount rate rises and revenue growth forecasts become more cautious. These factors indicate both increased risk and muted near-term optimism. Stay tuned to learn how investors and analysts can stay ahead as DarioHealth’s story continues to evolve. Analyst Price Targets don't always capture the full...